Study: Drug Candidate Improves Brain Energy Metabolism in Parkinson’s, MS

Top-line results from the Phase II REPAIR trial show a gold nanocrystal suspension, CNM-Au8®, significantly improved brain energetic metabolism in patients with Parkinson’s disease (PD) and multiple sclerosis (MS).